46 related articles for article (PubMed ID: 27926811)
21. NADPH oxidase p22phox and catalase gene variants are associated with biomarkers of oxidative stress and adverse outcomes in acute renal failure.
Perianayagam MC; Liangos O; Kolyada AY; Wald R; MacKinnon RW; Li L; Rao M; Balakrishnan VS; Bonventre JV; Pereira BJ; Jaber BL
J Am Soc Nephrol; 2007 Jan; 18(1):255-63. PubMed ID: 17151330
[TBL] [Abstract][Full Text] [Related]
22. Relationship between common functional polymorphisms of the p22phox gene (-930A > G and +242C > T) and nephropathy as a result of Type 2 diabetes in a Chinese population.
Lim SC; Goh SK; Lai YR; Tee WW; Koh A; Xu XH; Wu YS; Yap E; Subramaniam T; Sum CF
Diabet Med; 2006 Sep; 23(9):1037-41. PubMed ID: 16922713
[TBL] [Abstract][Full Text] [Related]
23. Relationship of p22phox C242T polymorphism with nephropathy in type 2 diabetic patients.
Santos KG; Canani LH; Gross JL; Tschiedel B; Souto KE; Roisenberg I
J Nephrol; 2005; 18(6):733-8. PubMed ID: 16358232
[TBL] [Abstract][Full Text] [Related]
24. Prevention of nephropathy in patients with type 2 diabetes mellitus.
Tzamaloukas AH; Murata GH
Int Urol Nephrol; 2005; 37(3):655-63. PubMed ID: 16307358
[TBL] [Abstract][Full Text] [Related]
25. Association of the p22phox component of NAD(P)H oxidase with susceptibility to diabetic nephropathy in patients with type 1 diabetes.
Hodgkinson AD; Millward BA; Demaine AG
Diabetes Care; 2003 Nov; 26(11):3111-5. PubMed ID: 14578247
[TBL] [Abstract][Full Text] [Related]
26. Statistical aspects of the analysis of data from retrospective studies of disease.
MANTEL N; HAENSZEL W
J Natl Cancer Inst; 1959 Apr; 22(4):719-48. PubMed ID: 13655060
[No Abstract] [Full Text] [Related]
27. C242T p22phox gene polymorphism in the population of Han nationality in Guangdong province.
Ji Z; Lu BX; Wang XY; Pan SY
Di Yi Jun Yi Da Xue Xue Bao; 2003 Apr; 23(4):387-8, 390. PubMed ID: 12697486
[TBL] [Abstract][Full Text] [Related]
28. Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis.
Guzik TJ; West NE; Black E; McDonald D; Ratnatunga C; Pillai R; Channon KM
Circulation; 2000 Oct; 102(15):1744-7. PubMed ID: 11023926
[TBL] [Abstract][Full Text] [Related]
29. C242T polymorphism of NADPH oxidase p22 PHOX gene and ischemic cerebrovascular disease in the Japanese population.
Ito D; Murata M; Watanabe K; Yoshida T; Saito I; Tanahashi N; Fukuuchi Y
Stroke; 2000 Apr; 31(4):936-9. PubMed ID: 10754002
[TBL] [Abstract][Full Text] [Related]
30. A variant of p22(phox), involved in generation of reactive oxygen species in the vessel wall, is associated with progression of coronary atherosclerosis.
Cahilly C; Ballantyne CM; Lim DS; Gotto A; Marian AJ
Circ Res; 2000 Mar; 86(4):391-5. PubMed ID: 10700443
[TBL] [Abstract][Full Text] [Related]
31. The p22 phox polymorphism C242T is not associated with CHD risk in Asian Indians and Chinese.
Saha N; Sanghera DK; Kamboh MI
Eur J Clin Invest; 1999 Dec; 29(12):999-1002. PubMed ID: 10583446
[TBL] [Abstract][Full Text] [Related]
32. Relationship of the C242T p22phox gene polymorphism to angiographic coronary artery disease and endothelial function.
Li A; Prasad A; Mincemoyer R; Satorius C; Epstein N; Finkel T; Quyyumi AA
Am J Med Genet; 1999 Sep; 86(1):57-61. PubMed ID: 10440830
[TBL] [Abstract][Full Text] [Related]
33. Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease.
Inoue N; Kawashima S; Kanazawa K; Yamada S; Akita H; Yokoyama M
Circulation; 1998 Jan; 97(2):135-7. PubMed ID: 9445163
[TBL] [Abstract][Full Text] [Related]
34. Bias in meta-analysis detected by a simple, graphical test.
Egger M; Davey Smith G; Schneider M; Minder C
BMJ; 1997 Sep; 315(7109):629-34. PubMed ID: 9310563
[TBL] [Abstract][Full Text] [Related]
35. Elimination of false negative results in the two-hybrid system in the phagocyte NADPH oxidase.
Hong YR; Han L; Huang J; Kleinberg ME
Kaohsiung J Med Sci; 1996 May; 12(5):301-5. PubMed ID: 8676437
[TBL] [Abstract][Full Text] [Related]
36. The effectiveness of adjustment by subclassification in removing bias in observational studies.
Cochran WG
Biometrics; 1968 Jun; 24(2):295-313. PubMed ID: 5683871
[No Abstract] [Full Text] [Related]
37. Meta-analysis in clinical trials.
DerSimonian R; Laird N
Control Clin Trials; 1986 Sep; 7(3):177-88. PubMed ID: 3802833
[TBL] [Abstract][Full Text] [Related]
38. p22phox C242T gene polymorphism and overt diabetic nephropathy: a meta-analysis of 1,452 participants.
Li YY; Gong G; Geng HY; Qian Y
Korean J Intern Med; 2017 Nov; 32(6):1045-1052. PubMed ID: 27926811
[TBL] [Abstract][Full Text] [Related]
39. Association between the C242T polymorphism of p22phox gene and ischemic stroke: a meta-analysis.
Gu L; Su L; Liang B; Tang N; Long J; Tan J; Chen Q; Xie J; Wu G; Yan Y; Huang G; Zu X
J Neurol Sci; 2013 Jul; 330(1-2):100-10. PubMed ID: 23684671
[TBL] [Abstract][Full Text] [Related]
40. Association between the RAGE gene -374T/A, -429T/C polymorphisms and diabetic nephropathy: a meta-analysis.
Shi Z; Lu W; Xie G
Ren Fail; 2015 Jun; 37(5):751-6. PubMed ID: 25707513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
